

(Sharecast News) - Alternative capital provider Duke Royalty updated the market on trading in its fourth quarter on Monday, reporting cash revenue fro...


(Sharecast News) - Duke Royalty: Canaccord reiterates buy with a target price of 45p.


DIRECTOR DEALINGS: Silence Therapeutics top team buy USD540,000 worth


IN BRIEF: Duke Royalty raises GBP3 million via PrimaryBid offer


IN BRIEF: Duke Royalty raises GBP32 million to fund investments


IN BRIEF: Duke Royalty to raise around GBP33 million for investments


IN BRIEF: Duke Royalty increases credit facility to GBP35 million


(Sharecast News) - Moonpig Group: Citigroup initiates at buy with a target price of 550p.